Current filters:


8626 to 8635 of 95986 results

Eli Lilly 3rd-qtr 2011 sales grow 9% but costs hit profits


US drug major Eli Lilly (NYSE: LLY) posted financial results for the third quarter of 2011 showing that,…

Eli LillyFinancialPharmaceutical

Syntaxin and Ipsen in up to $99 million collaboration on novel botulinum-toxin therapeutics


French drugmaker Ipsen (Euronext: IPN) has entered into a global strategic collaboration with privately-held…


Executive appointments at Bristol-Myers Squibb and Amgen


US drug major Bristol-Myers Squibb (NYSE: BMY) has announced a series of related changes within its senior…

AmgenBiotechnologyBristol-Myers SquibbManagementPharmaceutical

Benefits of Boehringer’s Pradaxa come at high cost, study finds


Treating patients with the new blood thinning medication dabigatran (German independent drug major Boehringer…

Boehringer IngelheimCardio-vascularNorth AmericaPharmaceuticalPradaxaPricing

Prasco selected as Eli Lilly authorized generics partner for Zyprexa


Privately-held US drugmaker Prasco Laboratories says it has signed a marketing and distribution agreement…

Eli LillyGenericsMarkets & MarketingNeurologicalNorth AmericaPrasco LaboratoriesZyprexa

Over 230K US pharma jobs will be lost under proposed mandatory Part D drug rebates, says think tank


US President Barack Obama and some members of Congress have proposed requiring that prescription drug…

HealthcareNorth AmericaPharmaceuticalPoliticsPricingResearch

Sun Pharma offers to acquire remainder of Taro shares


Indian drugmaker Sun Pharmaceuticals (SUN: BO) has proposed to acquire the remaining shares of Israel-based…

GenericsMergers & AcquisitionsPharmaceuticalSun Pharmaceutical IndustriesTaro Pharmaceuticals

8626 to 8635 of 95986 results

Back to top